The 2025 Western Section AUA annual meeting featured a kidney cancer session and a presentation by Jaxson Jeffery discussing the impact of neoadjuvant systemic therapy on tumor and tumor thrombus ...

Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but ...

Renal cell carcinoma is the most common form of kidney cancer. It can take time to fully process a diagnosis and what, ...

As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...

The combination of Merck's Welireg and Eisai's Lenvima has not yet shown statistical significance in extending overall ...

A study on kidney cancer rates released in October shows the rate of kidney cancer in Merrimack is 38% higher than in the rest of the state. The research is part of a long-term investigation that ...